Search research articles
Contact Us
Filters
Showing results (31-40 of 54) with videos related to
Page
of 6
Sort By:
Actas Urologicas Espanolas
|
December 3, 2016
Systematic review of perioperative outcomes and complications after open, laparoscopic and robot-assisted radical cystectomy
A Palazzetti, R Sanchez-Salas, P Capogrosso, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
September 19, 2017
[Management of ablative therapies in prostate cancer]
E Barret, R Sanchez-Salas, M Galiano, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
June 2, 2022
Renal tumor biopsy does not increase the risk of surgical complications of minimally invasive partial nephrectomy
D Pasquier, F Rozet, A Fregeville, et al.
Actas Urologicas Espanolas
|
April 1, 2019
Immediate versus delayed prostatectomy and the fate of patients who progress to a higher risk disease on active surveillance
A Mallya, V Senguttuvan-Karthikeyan, A Sivaraman, et al.
Actas Urologicas Espanolas
|
April 3, 2018
Predictors of early, intermediate and late biochemical recurrence after minimally invasive radical prostatectomy in a single-centre cohort with a mean follow-up of 8 years
S García-Barreras, I Nunes, V Srougi, et al.
European Urology Focus
|
April 18, 2018
Medium-term Follow-up of Vascular-targeted Photodynamic Therapy of Localized Prostate Cancer Using TOOKAD Soluble WST-11 (Phase II Trials)
A Noweski, A Roosen, S Lebdai, et al.
World Journal of Urology
|
February 26, 2015
TOOKAD® Soluble focal therapy: pooled analysis of three phase II studies assessing the minimally invasive ablation of localized prostate cancer
A R Azzouzi, E Barret, J Bennet, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
September 24, 2017
[Evaluation and results of ablative therapies in prostate cancer]
R Renard-Penna, R Sanchez-Salas, E Barret, et al.
Actas Urologicas Espanolas
|
March 13, 2019
Oncological outcomes and pathological characteristics of cT1 upstaging to pT3a renal cell carcinoma compared with de novo pT3a tumors
V Senguttuvan Karthikeyan, A Mallya, A Sivaraman, et al.
Diagnostic and Interventional Imaging
|
February 26, 2018
Transition zone and anterior stromal prostate cancers: Evaluation of discriminant location criteria using multiparametric fusion-guided biopsy
S Tavolaro, P Mozer, M Roupret, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 54) with videos related to
Sort By:
Page
of 6
Actas Urologicas Espanolas
|
December 3, 2016
Systematic review of perioperative outcomes and complications after open, laparoscopic and robot-assisted radical cystectomy
A Palazzetti, R Sanchez-Salas, P Capogrosso, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
September 19, 2017
[Management of ablative therapies in prostate cancer]
E Barret, R Sanchez-Salas, M Galiano, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
June 2, 2022
Renal tumor biopsy does not increase the risk of surgical complications of minimally invasive partial nephrectomy
D Pasquier, F Rozet, A Fregeville, et al.
Actas Urologicas Espanolas
|
April 1, 2019
Immediate versus delayed prostatectomy and the fate of patients who progress to a higher risk disease on active surveillance
A Mallya, V Senguttuvan-Karthikeyan, A Sivaraman, et al.
Actas Urologicas Espanolas
|
April 3, 2018
Predictors of early, intermediate and late biochemical recurrence after minimally invasive radical prostatectomy in a single-centre cohort with a mean follow-up of 8 years
S García-Barreras, I Nunes, V Srougi, et al.
European Urology Focus
|
April 18, 2018
Medium-term Follow-up of Vascular-targeted Photodynamic Therapy of Localized Prostate Cancer Using TOOKAD Soluble WST-11 (Phase II Trials)
A Noweski, A Roosen, S Lebdai, et al.
World Journal of Urology
|
February 26, 2015
TOOKAD® Soluble focal therapy: pooled analysis of three phase II studies assessing the minimally invasive ablation of localized prostate cancer
A R Azzouzi, E Barret, J Bennet, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
September 24, 2017
[Evaluation and results of ablative therapies in prostate cancer]
R Renard-Penna, R Sanchez-Salas, E Barret, et al.
Actas Urologicas Espanolas
|
March 13, 2019
Oncological outcomes and pathological characteristics of cT1 upstaging to pT3a renal cell carcinoma compared with de novo pT3a tumors
V Senguttuvan Karthikeyan, A Mallya, A Sivaraman, et al.
Diagnostic and Interventional Imaging
|
February 26, 2018
Transition zone and anterior stromal prostate cancers: Evaluation of discriminant location criteria using multiparametric fusion-guided biopsy
S Tavolaro, P Mozer, M Roupret, et al.
Page
of 6